M

Mednet

Specialized oncology knowledge platform for clinicians

Growth Marketing Lead

Full-Time
$125k - $175k/yr
Senior
New York, NY, USA
In Person
Growth & MarketingGrowth Marketing

About the job

Requirements
  • At least 5 years of growth, acquisition, or performance marketing experience, ideally at an early-stage startup where the candidate handled several responsibilities.
  • A track record of finding and scaling acquisition channels from scratch, rather than only optimizing an established single channel.
  • An experiment-first approach: framing hypotheses, running frequent tests, and distinguishing meaningful results from noise.
  • Strong creative and writing instincts, including the ability to write sharp copy and guide creative direction.
  • Experience running email as a growth channel, including list segmentation, personalization at scale, deliverability, and keeping a large list engaged.
  • Comfort with analytics and attribution, including building and interpreting a funnel report and acting on the findings independently.
  • Ability to operate autonomously on a small, fast-moving team, set priorities, and own outcomes.
Responsibilities
  • Own top-of-funnel growth, including how physicians discover Mednet, why they register, and registration volume.
  • Identify and test acquisition channels, including paid, organic, referral, partnerships, outbound, and content; scale effective channels and discontinue ineffective ones.
  • Run a high-velocity experimentation program across messaging, audiences, creative, and channels, and assess what each test demonstrates.
  • Build acquisition campaigns that speak credibly to physicians, including specialty-level targeting and positioning aligned with doctors’ views of their practices.
  • Run and improve the email acquisition engine, using the physician contact pool, invite program, and newsletter through segmentation and personalization at scale.
  • Own acquisition messaging and creative direction, with creative support for asset production.
  • Partner with lifecycle and product teams to transition newly acquired physicians into onboarding.
  • Work with data to instrument the funnel, define needed events and sources, and report on acquisition cost, conversion, and the quality of acquired physicians.
Desired Qualifications
  • Experience marketing to credentialed or high-trust professional audiences, such as physicians, attorneys, or financial advisors; candidates from adjacent backgrounds are considered if they understand the importance of relevance and credibility.
  • Experience marketing specifically to physicians or other healthcare professionals.
  • Background with community, marketplace, or user-generated-content products where growth depends on more than a one-time signup.
  • Hands-on experience with paid channels such as Meta, Google, or LinkedIn, including the conversion tracking behind them.
  • Experience with analytics tools such as Google Analytics, Mixpanel, or Amplitude.

About the company

theMednet provides a specialized online platform that shares expert oncology knowledge sourced from National Cancer Institute Cancer Center Tumor Boards. It targets healthcare professionals and researchers, offering access to curated opinions and treatment insights to support clinical decision-making. Access is via a subscription model and partnerships with medical institutions, enabling members to view tumor board discussions, expert commentary, and research ideas that inform patient care. The platform differentiates itself by focusing on tumor-board-level expertise and formal collaborations with cancer centers, rather than general medical information. Its goal is to improve patient outcomes and accelerate cancer research by giving clinicians and researchers reliable, board-vetted guidance when planning treatment and evaluating new research directions.

Company Size

11-50

Company Stage

Grant

Total Funding

$1.7M

Headquarters

New York City, New York

Founded

2014

Get referred to Mednet

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • TrialMatch launched August 20, 2026, with a $2 million NCI SBIR/STTR contract.
  • SWOG started a six-month study on August 21, 2026, to test referral lift.
  • Mednet added 3,700 experts across 23 specialties, expanding non-oncology monetization beyond cancer.

What critics are saying

  • A $2 million NCI contract expires after TrialMatch evaluation, leaving revenue dependence unchanged.
  • Flatiron Health, Tempus, and hospital EHRs already own oncology trial workflows.
  • If oncologists stop posting, Mednet's knowledge graph and TrialMatch relevance collapse quickly.

What makes Mednet unique

  • Mednet is the largest U.S. oncologist community, with 45,000 physicians and 22,000 discussions.
  • TrialMatch embeds trial discovery inside physician Q&A, not a standalone registry, since August 2026.
  • NCI-funded workflows and SWOG validation anchor clinical credibility with academic oncology leaders.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

6%

2 year growth

0%
Scientist Live
Aug 21st, 2026
Mednet launches new clinical trial discovery tool.

Mednet launches new clinical trial discovery tool. Published: 21 August 2026 Mednet has launched TrialMatch, a clinical trial discovery tool designed to help oncologists identify relevant cancer trials in minutes. Developed through a $2 million contract awarded by the National Cancer Institute (NCI) Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR), TrialMatch brings clinical trial discovery into the physician workflow Clinical trial enrollment is still a challenge in oncology. 20% of trials close prematurely due to insufficient enrollment, while 93% of adults with cancer never participate in a clinical trial. Eligible patients exist, but identifying appropriate trials requires physicians to navigate complex eligibility criteria and trial registries designed for researchers instead of practising physicians. TrialMatch addresses both sides of this challenge: enabling oncologists to find relevant trials for their patients, and helping trials find the physicians already caring for potentially eligible patients. Using Mednet AI, Mednet's clinical assistant, oncologists can describe a patient profile in natural language and identify open trials matched on factors such as diagnosis, stage, biomarkers, and location. Results include match rationales and enrollment links, helping physicians evaluate potential opportunities without leaving their clinical workflow. TrialMatch also operates within Mednet's physician community, where oncologists ask questions, discuss challenging cases, and share clinical experience with peers. There, TrialMatch surfaces enrolling trials within the 22,000+ conversations where physicians are seeking guidance. Nadine Housri, MD, co-founder and chief medical officer of Mednet, said, "Finding the right clinical trial shouldn't require physicians to step away from patient care and search through multiple databases. But discovery is only one part of the challenge. Physicians need easier ways to identify appropriate trials for their patients, and trials need better ways to reach the clinicians caring for those patients. TrialMatch brings both sides together by making clinical trial discovery part of the everyday practice of medicine." Over 45,000 physicians across 23 specialities use Mednet to discuss complex clinical questions, share insights, and learn from each other's experience. In addition to supporting the development of TrialMatch, the NCI SBIR/STTR contract funds a prospective evaluation of the tool in collaboration with the SWOG Cancer Research Network, one of five adult cooperative groups in the NCI-sponsored National Clinical Trials Network (NCTN). The study will examine whether AI-assisted trial matching increases physician awareness of clinical trials and ultimately improves patient enrollment. SWOG has led many of oncology's most influential practice-changing clinical trials over the past several decades, and the collaboration brings SWOG's commitment to scientific rigour and evidence-based evaluation to the development and validation of TrialMatch. TrialMatch is available now at no cost to oncologists through Mednet AI and across Mednet's physician community.

HIStalk Practice
Jun 25th, 2025
Home " News " Currently Reading:

EqualizeRCM invests in MedNet, which specializes in RCM services for physician practices and durable medical equipment providers.